No connection

Search Results

BXC

BEARISH
$58.35 Live
BlueLinx Holdings Inc. · NYSE
Target $70.0 (+20.0%)
$44.78 52W Range $88.3
Overview AI Snowflake Price Valuation Profitability Growth Health Statements Peers Insiders SEC Filings

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Apr 25, 2026
Market cap
$459.05M
P/E
2917.5
ROE
0.0%
Profit margin
0.0%
Debt/Equity
1.09
Dividend yield
N/A

AI Analysis

AI-powered fundamental assessment

Confidence
85%
BXC exhibits severe fundamental deterioration, characterized by a Piotroski F-Score of 4/9 (Stable) but offset by a catastrophic collapse in earnings power. The stock trades at a massive premium to its Graham Number ($5.94) and Intrinsic Value ($0.14), with a current P/E of 2917.50 reflecting near-zero profitability. While the balance sheet remains liquid with a Current Ratio of 4.66, the consistent failure to meet earnings estimates (0/4 beats) and a -175.8% YoY EPS growth indicate a business in a deep cyclical or structural decline.

Key Strengths

Strong short-term liquidity with a Current Ratio of 4.66
Trading below book value (Price/Book: 0.74)
Low Price/Sales ratio (0.16) suggesting high revenue relative to market cap
Manageable Debt/Equity ratio of 1.09
Positive Quick Ratio (2.86) indicating ability to cover immediate liabilities

Key Risks

Extreme valuation gap between current price ($58.35) and Graham Number ($5.94)
Near-zero profit margins (0.01% Profit Margin)
Severe earnings collapse with YoY EPS growth of -175.8%
Consistent earnings misses (0/4 in last 4 quarters) with average surprise of -20.87%
Stagnant revenue growth (0.70% YoY) in a volatile industrial sector
AI Fair Value Estimate
Based on comprehensive analysis
$8.5
-85.4% below current price

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
26
Weak
Value
15
Future
20
Past
40
Health
55
Dividend
0
AI Verdict
High Risk / Value Trap
Key drivers: Earnings collapse, Extreme P/E ratio, Negative technical trend, Massive divergence from deterministic fair value
Confidence
90%
Value
15/100

Ref P/E, PEG, Graham Number

Positives
  • Low P/B ratio (0.74)
Watchpoints
  • P/E of 2917.50
  • Price is ~10x the Graham Number
  • Intrinsic value is negligible ($0.14)
Future
20/100

Ref Growth rates

Positives
  • Forward P/E (21.26) suggests expected recovery
Watchpoints
  • Flat revenue growth (0.70%)
  • Deeply negative EPS growth
  • Consistent earnings misses
Past
40/100

Ref Historical trends

Positives
  • Strong performance in 2021-2022
Watchpoints
  • 1Y return of -21.2%
  • Rapid decay in quarterly EPS progression
Health
55/100

Ref Altman Z-Score, Piotroski F-Score

Positives
  • High Current Ratio (4.66)
  • Piotroski F-Score of 4/9 (Stable)
Watchpoints
  • Low ROE (0.03%)
  • Lack of Altman Z-Score data
Dividend
0/100

Ref Yield, Payout

Positives
No standout positives identified.
Watchpoints
  • No dividend yield
  • 0/100 Dividend Strength

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$58.35
Analyst Target
$70.0
Upside/Downside
+20.0%

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for BXC and closest competitors.

Updated 2026-04-24
BXC
BlueLinx Holdings Inc.
Primary
5Y
+16.5%
3Y
-16.1%
1Y
-21.2%
6M
-19.6%
1M
+9.3%
1W
+0.1%
SBC
SBC Medical Group Holdings Incorporated
Peer
5Y
-54.9%
3Y
-57.0%
1Y
+11.7%
6M
+7.0%
1M
+28.3%
1W
+8.2%
CYR
Cryoport, Inc.
Peer
5Y
-82.9%
3Y
-56.6%
1Y
+67.8%
6M
-6.0%
1M
+13.8%
1W
+11.2%
ISS
Innovative Aerosystems, Inc.
Peer
5Y
+288.5%
3Y
+235.2%
1Y
+335.5%
6M
+118.7%
1M
-16.0%
1W
+11.8%
ACT
Acacia Research Corporation
Peer
5Y
-23.6%
3Y
+8.4%
1Y
+35.2%
6M
+48.3%
1M
+20.2%
1W
+19.6%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
2917.5
Forward P/E
21.26
PEG Ratio
2.19
P/B Ratio
0.74
P/S Ratio
0.16
EV/Revenue
0.25
EV/EBITDA
10.6
Market Cap
$459.05M

Profitability

Profit margins and return metrics

Profit Margin 0.01%
Operating Margin 0.03%
Gross Margin 15.29%
ROE 0.03%
ROA 1.22%

Growth

Revenue and earnings growth rates

Revenue Growth +0.7%
Earnings Growth N/A
Q/Q Revenue Growth +0.73%
Q/Q Earnings Growth N/A

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
1.09
Moderate
Current Ratio
4.66
Strong
Quick Ratio
2.86
Excellent
Cash/Share
$49.05

Financial Statement Flow

Interactive flow visualization showing how money moves through the company Q4 2025

Revenue
$0.7B
Gross Margin
15.7%
Op. Margin
-0.5%
Net Margin
-1.2%
Total Assets
$1.5B
Liabilities
$0.9B
Equity
$0.6B
Debt/Equity
1.51x
Operating CF
$0.1B
CapEx
$-0.0B
Free Cash Flow
$0.1B
FCF Yield
91%

Quarterly Earnings History

EPS performance vs analyst estimates

2026-05-05
$N/A
2026-02-24
$-0.47
-11.2% surprise
2025-11-04
$0.2
-38.5% surprise
2025-07-29
$0.54
-12.9% surprise

Industrials Sector Comparison

Comparing BXC against 393 companies in the Industrials sector (30 bullish, 134 neutral, 229 bearish)
P/E Ratio
2917.5
This Stock
vs
82.55
Sector Avg
+3434.4% (Expensive)
Return on Equity (ROE)
0.03%
This Stock
vs
-24.72%
Sector Avg
-100.1% (Below Avg)
Profit Margin
0.01%
This Stock
vs
6.51%
Sector Avg
-99.9% (Weaker)
Debt to Equity
1.09
This Stock
vs
2.88
Sector Avg
-62.1% (Less Debt)
Revenue Growth
0.7%
This Stock
vs
82.87%
Sector Avg
-99.2% (Slower)
Current Ratio
4.66
This Stock
vs
3.2
Sector Avg
+45.7% (Stronger)

Similar Companies

Peer comparison within the same industry

BXC BlueLinx Holdings Inc.
BEARISH
Mkt Cap
$459M
P/E
2917.5
ROE
0.0%
Price
$58.35
SBC SBC Medical...
NEUTRAL
Mkt Cap
$461M
P/E
9.0
ROE
22.3%
Price
$4.49
 Compare with BXC
CYRX Cryoport, Inc.
NEUTRAL
Mkt Cap
$461M
P/E
-
ROE
-7.5%
Price
$9.21
 Compare with BXC
ISSC Innovative...
BULLISH
Mkt Cap
$447M
P/E
23.7
ROE
32.5%
Price
$25.17
 Compare with BXC
ACTG Acacia...
BEARISH
Mkt Cap
$471M
P/E
81.3
ROE
4.3%
Price
$4.88
 Compare with BXC

SEC Filings

Recent regulatory filings from the SEC EDGAR database

DEF 14A
DEF 14A
2026-04-09

BXC filed a definitive proxy statement on April 9, 2026, providing shareholders with necessary information and voting materials for an upcoming meeting.

10-K
10-K
2026-02-24

BlueLinx Holdings Inc. (BXC) filed its 10-K on February 24, 2026, covering the fiscal year ended January 3, 2026. The provided excerpts contain the filing's structural framework and table of contents but do not include specific financial performance metrics or detailed risk disclosures.

8-K
8-K
2026-02-24

BXC filed an 8-K on February 24, 2026, likely to announce its quarterly financial results.

8-K
FORM 8-K
2026-02-06

BXC filed an 8-K on February 6, 2026, likely to announce its fourth quarter and full-year financial results.

8-K
FORM 8-K
2025-12-15
10-Q
10-Q
2025-11-04

BXC filed its quarterly 10-Q report on November 4, 2025. While specific financial metrics were not provided in the excerpt, the filing includes a detailed section on Risk Factors under Item 1A.

8-K
8-K
2025-11-04

BXC filed an 8-K on November 4, 2025, likely to announce its third-quarter financial results.

8-K
FORM 8-K
2025-11-03

BXC filed an 8-K on November 3, 2025, likely to announce its third-quarter financial results.

8-K
FORM 8-K
2025-09-26
8-K
FORM 8-K
2025-08-28
10-Q
10-Q
2025-07-29
8-K
8-K
2025-07-29
8-K
FORM 8-K
2025-06-11
8-K
FORM 8-K
2025-05-21
8-K
FORM 8-K
2025-05-13
Data sourced from SEC EDGAR. AI summaries generated automatically.

Wall Street Analysts

Professional analyst ratings and price targets

Consensus
NONE
3 analysts
Benchmark
2026-02-27
Maintains
Buy Buy
DA Davidson
2025-11-06
Maintains
Neutral Neutral

Past News Coverage

Recent headlines mentioning BXC from our newsroom.

Newest → oldest
Back to All Stocks
TradingGPT V2 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Features Terminal AI Assistant Analysis Market News Pricing
Start Trading with AI Already have an account? Sign In
Home
Terminal
AI Chat
Markets
Profile